AKI in severe sepsis. Keir and Kellum. 2015. JVECC Flashcards
What does RIFLE stand for?
Risk
Injury
Failure
Loss of kidney function
End-stage kidney disease
How are the RIFLE stages defined?
What are the stages of KDIGO and how are they defined?
On histopathology how does sepsis from AKI differ from AKI from nephrotoxins or ischemia?
- Sepsis-induced AKI typically has only mild histological changes, some patchy tubular changes with little necrosis
- Ischema/Nephrotoxin-induced AKI: diffuse glomerular and tubular damage with extensive necrosis
What pro-inflammatory cytokine concentration has been correlated with the risk of AKI in people with CAP?
Interleukin-6
Explain how tubular epithelial dysfunction leads to a decreased UOP and increased serum creatinine
- tubular dysfunction results in decreased NaCl absorption –> increased NaCl delivered to macula densa cells –> tubuloglomerular feedback mechanism –> vasoconstriction of afferent arteriole –> decreased GFR
- disruption of tight junctions between renal tubular epithelian cells –> back leakage of tubular fluid across the epithelium
- loss of cellular adhesion to the basement membrane –> shedding of epithelial cells –> casts in urine and blockage of tubules
What are the steps following sublethal cellular injury to the kidneys?
repair
* death if damaged beyond recovery
* infiltration of mononuclear cells
* repair or death choice mediated by cyclindependent kinase inhibitors
regeneration
* stem cells appear
proliferation
* marked proliferation of surviving tubular cells
* influenced by growth factor
List early markers of AKI
- NGAL
- Kidney injury molecule-1
- cystatin C
- liver fatty acid binding protein
- G1-G0 cell cycle arrest biomarkes (metalloproteinases-2 and inuslin-like growth factor binding protein-7
What are the IRIS AKI grades and how are they defined?
Grade I
* non-azotemic, i.e., creatinine < 1.6 mg/dL with 0.3 mg/dL rise
Grade II
* creatinine 1.7-2.5 mg/dL
Grade III
* creatinine 2.6-5.0 mg/dL
Grade IV
* creatinine 5.1-10 mg/dL
Grade V
* creatinine >10.0 mg/dL
List biomarkers of early AKI evaluated in dogs
- urinary neutrophil gelatinase-associated lipocalin (NGAL)
- urinary cystatin-C
- urinary NAG (n-acetyl-beta-D-glucosaminidse)
- urinary retinol binding protein
How does dopamine improve renal blood flow?
- improves cardiac output through systemic cardiovascular effects
- dilates renal afferent and efferent arterioles via local dopaminergic receptors
What are the renal dopamine receptors?
mainly D1 and D5
What is the only indication of Furosemide in AKI?
- regulating fluid balance if fluid overloaded
What are the current arguments against Dopamine use in AKI?
- negative studies on renal vasodilatory effects
- renal effects seen in healthy patients not preserved in face of AKI
- can cause increased vascular resistance and reduced RBF
- side effects: tachyarrhythmias, myocardial hypoxia, reduced splanchnic blood flow, suppressed T cell function
What is the mechanism of action of Fenoldopam?
pure dopamine type-1 receptor agonist
no alpha and beta adrenergic effects